Horizon 1 1 17 ACL : Articles dans des revues avec comité de lecture répertoriées par l'AERES Journal of Clinical Epidemiology 30-60 Scoping review COVID-19 Equity Inequity Testing programs HIV Ebola PROGRESS-Plus framework TIDieR-PHP MONDE 2022 fdi:010083948 ENG Journal of Clinical Epidemiology 0895-4356 ISI:000740331000004 10.1016/j.jclinepi.2021.11.030 https://www.documentation.ird.fr/hor/fdi:010083948 https://www.documentation.ird.fr/intranet/publi/2022-02/010083948.pdf 143 Horizon (IRD) Objective: This scoping review aimed to identify how equity has been considered in large-scale infectious disease testing initiatives. Study Design and Setting: Large-scale testing interventions are instrumental for infectious disease control and a central tool for the coronavirus 19 (COVID-19) pandemic. We searched Web of Science: core collection, Embase and Medline in June 2021 and followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses recommendations for scoping reviews. We critically analyzed the content of all included articles. Results: Our search resulted in 2448 studies of which 86 were included for data extraction after screening. Of the included articles, 80% reported on COVID-19 -related screening programs. None of the studies presented a formal definition of (in)equity in testing, however, 71 articles did indirectly include elements of equity through the justification of their target population. Of these 71 studies, 58% articles indirectly alluded to health equity according to the PROGRESS-Plus framework, an acronym used to identify a list of socially stratifying characteristics driving inequity in health outcomes. Conclusion: The studies included in our scoping review did not explicitly consider equity in their design or evaluation which is imperative for the success of infectious disease testing programs. 056 ; 052 UR196